nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—acquired immunodeficiency syndrome—sarcoma	0.638	1	CtDrD
Amprenavir—ABCC1—Dactinomycin—sarcoma	0.0437	0.132	CbGbCtD
Amprenavir—CYP2B6—Thiotepa—sarcoma	0.0428	0.13	CbGbCtD
Amprenavir—ABCC1—Mitoxantrone—sarcoma	0.0391	0.118	CbGbCtD
Amprenavir—ABCC1—Epirubicin—sarcoma	0.0317	0.0958	CbGbCtD
Amprenavir—ABCC1—Vincristine—sarcoma	0.0269	0.0815	CbGbCtD
Amprenavir—ABCC1—Etoposide—sarcoma	0.0247	0.0746	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—sarcoma	0.0168	0.0509	CbGbCtD
Amprenavir—CYP3A4—Thiotepa—sarcoma	0.0132	0.0398	CbGbCtD
Amprenavir—ABCB1—Dactinomycin—sarcoma	0.0106	0.0319	CbGbCtD
Amprenavir—CYP3A5—Vincristine—sarcoma	0.00998	0.0302	CbGbCtD
Amprenavir—ABCB1—Mitoxantrone—sarcoma	0.00944	0.0286	CbGbCtD
Amprenavir—CYP3A5—Etoposide—sarcoma	0.00915	0.0277	CbGbCtD
Amprenavir—CYP2C8—Etoposide—sarcoma	0.0088	0.0266	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—sarcoma	0.00792	0.024	CbGbCtD
Amprenavir—ABCB1—Vincristine—sarcoma	0.0065	0.0197	CbGbCtD
Amprenavir—ABCB1—Etoposide—sarcoma	0.00595	0.018	CbGbCtD
Amprenavir—CYP3A4—Mitoxantrone—sarcoma	0.00566	0.0171	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—sarcoma	0.00406	0.0123	CbGbCtD
Amprenavir—CYP3A4—Vincristine—sarcoma	0.00389	0.0118	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—sarcoma	0.00383	0.0116	CbGbCtD
Amprenavir—CYP3A4—Etoposide—sarcoma	0.00357	0.0108	CbGbCtD
Amprenavir—Affective disorder—Mitoxantrone—sarcoma	0.00312	0.101	CcSEcCtD
Amprenavir—CYP3A4—Doxorubicin—sarcoma	0.00243	0.00736	CbGbCtD
Amprenavir—Amylase increased—Thiotepa—sarcoma	0.000952	0.0307	CcSEcCtD
Amprenavir—Transaminases increased—Thiotepa—sarcoma	0.000745	0.024	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Thiotepa—sarcoma	0.000499	0.0161	CcSEcCtD
Amprenavir—Opportunistic infection—Epirubicin—sarcoma	0.000453	0.0146	CcSEcCtD
Amprenavir—Opportunistic infection—Doxorubicin—sarcoma	0.000419	0.0135	CcSEcCtD
Amprenavir—Myositis—Epirubicin—sarcoma	0.000372	0.012	CcSEcCtD
Amprenavir—Myositis—Doxorubicin—sarcoma	0.000344	0.0111	CcSEcCtD
Amprenavir—Inflammation—Etoposide—sarcoma	0.000336	0.0108	CcSEcCtD
Amprenavir—Liver function test abnormal—Dactinomycin—sarcoma	0.000302	0.00971	CcSEcCtD
Amprenavir—Transaminases increased—Epirubicin—sarcoma	0.0003	0.00966	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.000296	0.00954	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.000294	0.00947	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00029	0.00934	CcSEcCtD
Amprenavir—Transaminases increased—Doxorubicin—sarcoma	0.000278	0.00894	CcSEcCtD
Amprenavir—Neutropenia—Dactinomycin—sarcoma	0.000264	0.0085	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Vincristine—sarcoma	0.000263	0.00846	CcSEcCtD
Amprenavir—Hyperglycaemia—Thiotepa—sarcoma	0.000257	0.00826	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.000256	0.00824	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.000251	0.00807	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00025	0.00803	CcSEcCtD
Amprenavir—Hepatobiliary disease—Thiotepa—sarcoma	0.00024	0.00772	CcSEcCtD
Amprenavir—Neutropenia—Vincristine—sarcoma	0.000236	0.00759	CcSEcCtD
Amprenavir—Neutropenia—Mitoxantrone—sarcoma	0.00023	0.00739	CcSEcCtD
Amprenavir—Depression—Vincristine—sarcoma	0.000224	0.00722	CcSEcCtD
Amprenavir—Connective tissue disorder—Thiotepa—sarcoma	0.000224	0.0072	CcSEcCtD
Amprenavir—Acute coronary syndrome—Vincristine—sarcoma	0.000222	0.00714	CcSEcCtD
Amprenavir—Hyperglycaemia—Mitoxantrone—sarcoma	0.000222	0.00713	CcSEcCtD
Amprenavir—Myocardial infarction—Vincristine—sarcoma	0.00022	0.0071	CcSEcCtD
Amprenavir—Acute coronary syndrome—Mitoxantrone—sarcoma	0.000216	0.00695	CcSEcCtD
Amprenavir—Myocardial infarction—Mitoxantrone—sarcoma	0.000215	0.00691	CcSEcCtD
Amprenavir—Erythema multiforme—Dactinomycin—sarcoma	0.000214	0.00688	CcSEcCtD
Amprenavir—Cardiac disorder—Thiotepa—sarcoma	0.000211	0.0068	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Etoposide—sarcoma	0.000209	0.00671	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Epirubicin—sarcoma	0.000201	0.00646	CcSEcCtD
Amprenavir—Mental disorder—Thiotepa—sarcoma	0.000199	0.00642	CcSEcCtD
Amprenavir—Connective tissue disorder—Vincristine—sarcoma	0.000198	0.00639	CcSEcCtD
Amprenavir—Malnutrition—Thiotepa—sarcoma	0.000198	0.00638	CcSEcCtD
Amprenavir—Neutropenia—Etoposide—sarcoma	0.000191	0.00615	CcSEcCtD
Amprenavir—Inflammation—Epirubicin—sarcoma	0.000188	0.00606	CcSEcCtD
Amprenavir—Cardiac disorder—Vincristine—sarcoma	0.000187	0.00603	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.000186	0.00598	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000181	0.00581	CcSEcCtD
Amprenavir—Acute coronary syndrome—Etoposide—sarcoma	0.00018	0.00578	CcSEcCtD
Amprenavir—Myocardial infarction—Etoposide—sarcoma	0.000179	0.00575	CcSEcCtD
Amprenavir—Mental disorder—Vincristine—sarcoma	0.000177	0.00569	CcSEcCtD
Amprenavir—Inflammation—Doxorubicin—sarcoma	0.000174	0.00561	CcSEcCtD
Amprenavir—Hepatobiliary disease—Etoposide—sarcoma	0.000172	0.00555	CcSEcCtD
Amprenavir—Myalgia—Thiotepa—sarcoma	0.000169	0.00543	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000168	0.00539	CcSEcCtD
Amprenavir—Myalgia—Dactinomycin—sarcoma	0.000167	0.00539	CcSEcCtD
Amprenavir—Discomfort—Dactinomycin—sarcoma	0.000165	0.00533	CcSEcCtD
Amprenavir—Nervous system disorder—Thiotepa—sarcoma	0.000159	0.00511	CcSEcCtD
Amprenavir—Skin disorder—Thiotepa—sarcoma	0.000157	0.00506	CcSEcCtD
Amprenavir—Erythema multiforme—Etoposide—sarcoma	0.000155	0.00498	CcSEcCtD
Amprenavir—Anorexia—Thiotepa—sarcoma	0.000154	0.00496	CcSEcCtD
Amprenavir—Anorexia—Dactinomycin—sarcoma	0.000153	0.00493	CcSEcCtD
Amprenavir—Diabetes mellitus—Epirubicin—sarcoma	0.000152	0.0049	CcSEcCtD
Amprenavir—Cardiac disorder—Etoposide—sarcoma	0.000152	0.00489	CcSEcCtD
Amprenavir—Myalgia—Vincristine—sarcoma	0.00015	0.00482	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000147	0.00474	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000146	0.00471	CcSEcCtD
Amprenavir—Myalgia—Mitoxantrone—sarcoma	0.000146	0.00469	CcSEcCtD
Amprenavir—Paraesthesia—Thiotepa—sarcoma	0.000145	0.00468	CcSEcCtD
Amprenavir—Discomfort—Mitoxantrone—sarcoma	0.000144	0.00463	CcSEcCtD
Amprenavir—Diabetes mellitus—Doxorubicin—sarcoma	0.000141	0.00454	CcSEcCtD
Amprenavir—Nervous system disorder—Vincristine—sarcoma	0.000141	0.00453	CcSEcCtD
Amprenavir—Decreased appetite—Thiotepa—sarcoma	0.000141	0.00453	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Thiotepa—sarcoma	0.00014	0.0045	CcSEcCtD
Amprenavir—Decreased appetite—Dactinomycin—sarcoma	0.00014	0.00449	CcSEcCtD
Amprenavir—Fatigue—Thiotepa—sarcoma	0.000139	0.00449	CcSEcCtD
Amprenavir—Fatigue—Dactinomycin—sarcoma	0.000138	0.00446	CcSEcCtD
Amprenavir—Anorexia—Vincristine—sarcoma	0.000137	0.0044	CcSEcCtD
Amprenavir—Skin disorder—Mitoxantrone—sarcoma	0.000136	0.00437	CcSEcCtD
Amprenavir—Anorexia—Mitoxantrone—sarcoma	0.000133	0.00429	CcSEcCtD
Amprenavir—Gastrointestinal pain—Thiotepa—sarcoma	0.000132	0.00426	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dactinomycin—sarcoma	0.000131	0.00423	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Vincristine—sarcoma	0.000131	0.00421	CcSEcCtD
Amprenavir—Paraesthesia—Vincristine—sarcoma	0.000129	0.00415	CcSEcCtD
Amprenavir—Abdominal pain—Thiotepa—sarcoma	0.000128	0.00412	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000127	0.0041	CcSEcCtD
Amprenavir—Abdominal pain—Dactinomycin—sarcoma	0.000127	0.00409	CcSEcCtD
Amprenavir—Paraesthesia—Mitoxantrone—sarcoma	0.000125	0.00404	CcSEcCtD
Amprenavir—Decreased appetite—Vincristine—sarcoma	0.000125	0.00401	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Vincristine—sarcoma	0.000124	0.00399	CcSEcCtD
Amprenavir—Fatigue—Vincristine—sarcoma	0.000124	0.00398	CcSEcCtD
Amprenavir—Liver function test abnormal—Epirubicin—sarcoma	0.000122	0.00394	CcSEcCtD
Amprenavir—Decreased appetite—Mitoxantrone—sarcoma	0.000121	0.00391	CcSEcCtD
Amprenavir—Fatigue—Mitoxantrone—sarcoma	0.00012	0.00388	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00012	0.00388	CcSEcCtD
Amprenavir—Discomfort—Etoposide—sarcoma	0.00012	0.00386	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000119	0.00384	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vincristine—sarcoma	0.000117	0.00378	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000117	0.00376	CcSEcCtD
Amprenavir—Asthenia—Thiotepa—sarcoma	0.000116	0.00374	CcSEcCtD
Amprenavir—Asthenia—Dactinomycin—sarcoma	0.000115	0.00371	CcSEcCtD
Amprenavir—Pruritus—Thiotepa—sarcoma	0.000114	0.00368	CcSEcCtD
Amprenavir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000114	0.00368	CcSEcCtD
Amprenavir—Abdominal pain—Vincristine—sarcoma	0.000113	0.00365	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—sarcoma	0.000113	0.00364	CcSEcCtD
Amprenavir—Skin disorder—Etoposide—sarcoma	0.000113	0.00363	CcSEcCtD
Amprenavir—Anorexia—Etoposide—sarcoma	0.000111	0.00357	CcSEcCtD
Amprenavir—Diarrhoea—Thiotepa—sarcoma	0.000111	0.00356	CcSEcCtD
Amprenavir—Abdominal pain—Mitoxantrone—sarcoma	0.00011	0.00355	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00011	0.00355	CcSEcCtD
Amprenavir—Diarrhoea—Dactinomycin—sarcoma	0.00011	0.00354	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000108	0.00348	CcSEcCtD
Amprenavir—Neutropenia—Epirubicin—sarcoma	0.000107	0.00345	CcSEcCtD
Amprenavir—Paraesthesia—Etoposide—sarcoma	0.000104	0.00336	CcSEcCtD
Amprenavir—Hyperglycaemia—Epirubicin—sarcoma	0.000103	0.00333	CcSEcCtD
Amprenavir—Asthenia—Vincristine—sarcoma	0.000103	0.00331	CcSEcCtD
Amprenavir—Vomiting—Thiotepa—sarcoma	0.000103	0.00331	CcSEcCtD
Amprenavir—Vomiting—Dactinomycin—sarcoma	0.000102	0.00329	CcSEcCtD
Amprenavir—Rash—Thiotepa—sarcoma	0.000102	0.00328	CcSEcCtD
Amprenavir—Dermatitis—Thiotepa—sarcoma	0.000102	0.00328	CcSEcCtD
Amprenavir—Headache—Thiotepa—sarcoma	0.000101	0.00326	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000101	0.00326	CcSEcCtD
Amprenavir—Rash—Dactinomycin—sarcoma	0.000101	0.00326	CcSEcCtD
Amprenavir—Decreased appetite—Etoposide—sarcoma	0.000101	0.00325	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Etoposide—sarcoma	0.0001	0.00323	CcSEcCtD
Amprenavir—Asthenia—Mitoxantrone—sarcoma	0.0001	0.00323	CcSEcCtD
Amprenavir—Fatigue—Etoposide—sarcoma	0.0001	0.00322	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—sarcoma	9.91e-05	0.00319	CcSEcCtD
Amprenavir—Diarrhoea—Vincristine—sarcoma	9.81e-05	0.00316	CcSEcCtD
Amprenavir—Hepatobiliary disease—Epirubicin—sarcoma	9.66e-05	0.00311	CcSEcCtD
Amprenavir—Nausea—Thiotepa—sarcoma	9.61e-05	0.00309	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—sarcoma	9.56e-05	0.00308	CcSEcCtD
Amprenavir—Diarrhoea—Mitoxantrone—sarcoma	9.56e-05	0.00308	CcSEcCtD
Amprenavir—Nausea—Dactinomycin—sarcoma	9.54e-05	0.00307	CcSEcCtD
Amprenavir—Gastrointestinal pain—Etoposide—sarcoma	9.5e-05	0.00306	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	9.37e-05	0.00302	CcSEcCtD
Amprenavir—Abdominal pain—Etoposide—sarcoma	9.19e-05	0.00296	CcSEcCtD
Amprenavir—Vomiting—Vincristine—sarcoma	9.12e-05	0.00294	CcSEcCtD
Amprenavir—Rash—Vincristine—sarcoma	9.04e-05	0.00291	CcSEcCtD
Amprenavir—Dermatitis—Vincristine—sarcoma	9.04e-05	0.00291	CcSEcCtD
Amprenavir—Connective tissue disorder—Epirubicin—sarcoma	9.01e-05	0.0029	CcSEcCtD
Amprenavir—Headache—Vincristine—sarcoma	8.99e-05	0.00289	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—sarcoma	8.94e-05	0.00288	CcSEcCtD
Amprenavir—Vomiting—Mitoxantrone—sarcoma	8.88e-05	0.00286	CcSEcCtD
Amprenavir—Rash—Mitoxantrone—sarcoma	8.81e-05	0.00284	CcSEcCtD
Amprenavir—Dermatitis—Mitoxantrone—sarcoma	8.8e-05	0.00283	CcSEcCtD
Amprenavir—Headache—Mitoxantrone—sarcoma	8.75e-05	0.00282	CcSEcCtD
Amprenavir—Erythema multiforme—Epirubicin—sarcoma	8.67e-05	0.00279	CcSEcCtD
Amprenavir—Nausea—Vincristine—sarcoma	8.52e-05	0.00274	CcSEcCtD
Amprenavir—Cardiac disorder—Epirubicin—sarcoma	8.51e-05	0.00274	CcSEcCtD
Amprenavir—Asthenia—Etoposide—sarcoma	8.34e-05	0.00268	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—sarcoma	8.34e-05	0.00268	CcSEcCtD
Amprenavir—Nausea—Mitoxantrone—sarcoma	8.3e-05	0.00267	CcSEcCtD
Amprenavir—Pruritus—Etoposide—sarcoma	8.22e-05	0.00265	CcSEcCtD
Amprenavir—Mental disorder—Epirubicin—sarcoma	8.03e-05	0.00259	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—sarcoma	8.02e-05	0.00258	CcSEcCtD
Amprenavir—Malnutrition—Epirubicin—sarcoma	7.98e-05	0.00257	CcSEcCtD
Amprenavir—Diarrhoea—Etoposide—sarcoma	7.95e-05	0.00256	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—sarcoma	7.87e-05	0.00253	CcSEcCtD
Amprenavir—Flatulence—Epirubicin—sarcoma	7.86e-05	0.00253	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—sarcoma	7.43e-05	0.00239	CcSEcCtD
Amprenavir—Vomiting—Etoposide—sarcoma	7.39e-05	0.00238	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—sarcoma	7.38e-05	0.00238	CcSEcCtD
Amprenavir—Rash—Etoposide—sarcoma	7.33e-05	0.00236	CcSEcCtD
Amprenavir—Dermatitis—Etoposide—sarcoma	7.32e-05	0.00236	CcSEcCtD
Amprenavir—Headache—Etoposide—sarcoma	7.28e-05	0.00234	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—sarcoma	7.28e-05	0.00234	CcSEcCtD
Amprenavir—Nausea—Etoposide—sarcoma	6.9e-05	0.00222	CcSEcCtD
Amprenavir—Myalgia—Epirubicin—sarcoma	6.79e-05	0.00219	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	6.75e-05	0.00217	CcSEcCtD
Amprenavir—Discomfort—Epirubicin—sarcoma	6.71e-05	0.00216	CcSEcCtD
Amprenavir—Nervous system disorder—Epirubicin—sarcoma	6.39e-05	0.00206	CcSEcCtD
Amprenavir—Skin disorder—Epirubicin—sarcoma	6.33e-05	0.00204	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—sarcoma	6.29e-05	0.00202	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	6.24e-05	0.00201	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—sarcoma	6.21e-05	0.002	CcSEcCtD
Amprenavir—Anorexia—Epirubicin—sarcoma	6.21e-05	0.002	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Epirubicin—sarcoma	5.93e-05	0.00191	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—sarcoma	5.91e-05	0.0019	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—sarcoma	5.85e-05	0.00188	CcSEcCtD
Amprenavir—Paraesthesia—Epirubicin—sarcoma	5.85e-05	0.00188	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—sarcoma	5.74e-05	0.00185	CcSEcCtD
Amprenavir—Decreased appetite—Epirubicin—sarcoma	5.66e-05	0.00182	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Epirubicin—sarcoma	5.62e-05	0.00181	CcSEcCtD
Amprenavir—Fatigue—Epirubicin—sarcoma	5.62e-05	0.00181	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—sarcoma	5.49e-05	0.00177	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—sarcoma	5.41e-05	0.00174	CcSEcCtD
Amprenavir—Gastrointestinal pain—Epirubicin—sarcoma	5.33e-05	0.00171	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—sarcoma	5.24e-05	0.00169	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—sarcoma	5.2e-05	0.00167	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—sarcoma	5.2e-05	0.00167	CcSEcCtD
Amprenavir—Abdominal pain—Epirubicin—sarcoma	5.15e-05	0.00166	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—sarcoma	4.93e-05	0.00159	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—sarcoma	4.76e-05	0.00153	CcSEcCtD
Amprenavir—Asthenia—Epirubicin—sarcoma	4.67e-05	0.0015	CcSEcCtD
Amprenavir—Pruritus—Epirubicin—sarcoma	4.61e-05	0.00148	CcSEcCtD
Amprenavir—Diarrhoea—Epirubicin—sarcoma	4.46e-05	0.00143	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—sarcoma	4.32e-05	0.00139	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—sarcoma	4.26e-05	0.00137	CcSEcCtD
Amprenavir—Vomiting—Epirubicin—sarcoma	4.14e-05	0.00133	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—sarcoma	4.12e-05	0.00133	CcSEcCtD
Amprenavir—Rash—Epirubicin—sarcoma	4.11e-05	0.00132	CcSEcCtD
Amprenavir—Dermatitis—Epirubicin—sarcoma	4.1e-05	0.00132	CcSEcCtD
Amprenavir—Headache—Epirubicin—sarcoma	4.08e-05	0.00131	CcSEcCtD
Amprenavir—Nausea—Epirubicin—sarcoma	3.87e-05	0.00125	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—sarcoma	3.83e-05	0.00123	CcSEcCtD
Amprenavir—Rash—Doxorubicin—sarcoma	3.8e-05	0.00122	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—sarcoma	3.8e-05	0.00122	CcSEcCtD
Amprenavir—Headache—Doxorubicin—sarcoma	3.78e-05	0.00122	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—sarcoma	3.58e-05	0.00115	CcSEcCtD
